Medical Device Gastrointestinal Stents Market | Page 2

REPORT DESCRIPTION
Gastrointestinal Stents Market – Overview
Market players are focusing on inorganic strategies such as mergers, acquisitions, or collaborations to
increase their foothold in the market. For instance, in May 2018, Olympus— a company that designs and
delivers innovative solutions for medical and surgical procedures—entered into an agreement with M.I.
Tech, a company that designs stents and other devices. Under this agreement, HANAROSTENT, biliary
and esophagus stents rolled in the EndoTherapy product portfolio of the company. The displacement of the
stents is a major issue faced after the stent is been placed. Targeting these issues, in 2017, W. L. Gore &
Associates, the manufacturer of Gore Viabil short wire biliary endoprosthesis stent, launched anti-
migration assurance program, under which device will be replaced within a period of one year if it
migrates. Furthermore, in 2016, Boston Scientific launched AXIOS stent and Electrocautery Enhanced
delivery system, endoscopic system used for minimally invasive treatment of pancreatitis, obtained as a
part of acquisition of Xlumena. In 2015, Cardinal Health announced acquisition of Cordis, business of
Johnson & Johnson, for US$ 1.944 Bn.